Crohn disease Trials in Atlanta, United States
Conditions / Crohn disease / Atlanta, United States
Clinical trials for Crohn disease investigate a range of treatment strategies and patient populations.
35 total trials for this combination
Showing top 10 of 35 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07196722 | A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease | RECRUITING | PHASE2/PHASE3 |
| NCT02596893 | Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease | TERMINATED | PHASE3 |
| NCT02403323 | Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 | TERMINATED | PHASE3 |
| NCT03467958 | An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease | TERMINATED | PHASE3 |
| NCT03816345 | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO | RECRUITING | — |
| NCT03440372 | Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease | TERMINATED | PHASE3 |
| NCT03464097 | A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease | TERMINATED | PHASE3 |
| NCT00261976 | A Long-term Safety Study of Infliximab (Remicade) | COMPLETED | — |
| NCT03440385 | Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease | COMPLETED | PHASE3 |
| NCT02394028 | A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease | COMPLETED | PHASE3 |